IL4 and chronic rhinosinusitis with nasal polyps: It is noteworthy that in one case, an interdisciplinary approach led to the use of dual biologic therapy: dupilumab (anti-IL-4) was prescribed for CRSwNP, and omalizumab (anti-IgE) was prescribed due to severe persistent asthma.